aTYR Pharma Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
aTYR Pharma Inc
CIK #0001339970
EDGAR Form CIK 2011 - 2026
10-K [0001339970]
10-Q [0001339970]
3 [0001339970]
4 [0001339970]
8-K [0001339970]
D [0001339970]
SC 13D [0001339970]
SC 13G [0001339970]
Form 13D/13G Filer Form 13D/13G Subject Filed
Vanguard Group Inc ATYR Pharma Inc [2025-07-29]
BlackRock Inc ATYR Pharma Inc [2025-07-17]
Point72 Asset Management LP ATYR Pharma Inc [2024-10-15]
Logos Global Management LP ATYR Pharma Inc [2024-01-02]
Lytton Laurence W ATYR Pharma Inc [2023-02-22]
Venrock Healthcare Capital Partners II LP ATYR Pharma Inc [2021-09-27]
Ikarian Capital LLC ATYR Pharma Inc [2021-09-17]
Tang Capital Partners LP ATYR Pharma Inc [2021-09-17]
Aspire Capital Fund LLC ATYR Pharma Inc [2021-02-17]
Alyeska Investment Group LP ATYR Pharma Inc [2021-02-16]
Altium Capital Management LP ATYR Pharma Inc [2020-02-18]
Renaissance Technologies LLC ATYR Pharma Inc [2020-02-12]
Federated Investors Inc /PA/ ATYR Pharma Inc [2019-04-22]
Schimmel Paul ATYR Pharma Inc [2018-09-10]
Redmile Group LLC ATYR Pharma Inc [2018-03-08]
Viking Global Investors LP ATYR Pharma Inc [2017-09-11]
EcoR1 Capital LLC ATYR Pharma Inc [2017-01-30]
Baker Bros Advisors LP ATYR Pharma Inc [2016-02-16]
RS Investment Management Co LLC ATYR Pharma Inc [2016-02-12]
Alta Partners VIII LP ATYR Pharma Inc [2016-02-12]
CHP II LP ATYR Pharma Inc [2016-02-04]
Domain Partners VIII LP ATYR Pharma Inc [2016-01-19]
FMR LLC ATYR Pharma Inc [2015-09-10]
Polaris Venture Partners V LP ATYR Pharma Inc [2015-05-22]
Sofinnova Venture Partners IX LP ATYR Pharma Inc [2015-05-15]
Flynn James E ATYR Pharma Inc [2015-05-13]
Form 3/4/5 Subject 2011 - 2026
Schimmel Paul
aTYR Pharma Inc
Coughlin Timothy
Zaknoen Sara
Gross Jane A
Lucas Svetlana
Benevich Eric
Broadfoot Jill Marie
Denyes Nancy
Shukla Sanjay
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
aTYR Pharma Inc ATYR
Common Stock
2026-02-04 Sell 1,558 $0.98 1,527
aTYR Pharma Inc ATYR
Common Stock
2026-02-04 Sell 1,118 $0.98 1,096
aTYR Pharma Inc ATYR
Common Stock
2026-02-04 Sell 3,745 $0.98 3,670
aTYR Pharma Inc ATYR
Restricted Stock Unit · derivative
2026-02-03 Option exercise 3,750 $0.00
aTYR Pharma Inc ATYR
Common Stock
2026-02-03 Option exercise 3,750
aTYR Pharma Inc ATYR
Restricted Stock Unit · derivative
2026-02-03 Option exercise 2,687 $0.00
aTYR Pharma Inc ATYR
Common Stock
2026-02-03 Option exercise 2,687
aTYR Pharma Inc ATYR
Common Stock
2026-02-03 Option exercise 10,375
aTYR Pharma Inc ATYR
Restricted Stock Unit · derivative
2026-02-03 Option exercise 10,375 $0.00
aTYR Pharma Inc ATYR
Employee Stock Options (right to buy) · derivative
2026-01-09 Grant 412,500 $0.00
aTYR Pharma Inc ATYR
Employee Stock Option (right to buy) · derivative
2026-01-09 Grant 1,500,000 $0.00
aTYR Pharma Inc ATYR
Employee Stock Option (right to buy) · derivative
2026-01-09 Grant 412,500 $0.00
aTYR Pharma Inc ATYR
Common Stock
2025-10-09 Buy 317,999 $0.94 298,919
aTYR Pharma Inc ATYR
Common Stock
2025-10-08 Buy 682,001 $0.90 613,801
aTYR Pharma Inc ATYR
Stock Option (right to buy) · derivative
2025-05-01 Grant 50,000 $0.00
aTYR Pharma Inc ATYR
Stock Option (right to buy) · derivative
2025-05-01 Grant 50,000 $0.00
aTYR Pharma Inc ATYR
Stock Option (right to buy) · derivative
2025-05-01 Grant 50,000 $0.00
aTYR Pharma Inc ATYR
Stock Option (right to buy) · derivative
2025-05-01 Grant 50,000 $0.00
aTYR Pharma Inc ATYR
Stock Option (right to buy) · derivative
2025-05-01 Grant 50,000 $0.00
aTYR Pharma Inc ATYR
Stock Option (right to buy) · derivative
2025-05-01 Grant 50,000 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com